Jorge DiMartino is VP at Kronos Bio, Inc. (KRON). They have made 6 open-market trades across 1 company since 2021, most recently 2024-01-04.
CIK 0001826732
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KRON | 315,246 | $277K |
Shares reported on the most recent Form 4, priced at the 2024-01-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KRON | SELL | 2024-01-04 | 2024-01-05 | $1.18 | $14K | -8.7% | -8.7% | +4.3% |
| KRON | SELL | 2023-12-12 | 2023-12-13 | $1.31 | $23K | -12.4% | -18.6% | -22.4% |
| KRON | SELL | 2023-07-06 | 2023-07-07 | $1.75 | $19K | +11.1% | -16.1% | -35.2% |
| KRON | SELL | 2023-02-24 | 2023-02-24 | $1.74 | $18K | -2.9% | -17.0% | -6.4% |
| KRON | SELL | 2022-12-12 | 2022-12-14 | $1.81 | $34K | -20.2% | +35.8% | -17.6% |
| KRON | SELL | 2021-12-13 | 2021-12-15 | $12.36 | $402K | +10.0% | -21.1% | -47.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.